Suppr超能文献

安博维薄膜包衣片(低剂量规格)中一种降解产物的鉴定与控制

Identification and control of a degradation product in Avapro film-coated tablet: low dose formulation.

作者信息

Wang George, Fiske John D, Jennings Scott P, Tomasella Frank P, Palaniswamy Venkatapuram A, Ray Kenneth L

机构信息

Analytical Research and Development, Research and Development, Bristol-Myers Squibb, New Brunswick, New Jersey, USA.

出版信息

Pharm Dev Technol. 2008;13(5):393-9. doi: 10.1080/10837450802244918.

Abstract

A degradation product was formed during the long-term stability studies (LTSS) of the low dose formulation of Avapro film-coated tablet. The degradant was identified as the hydroxymethyl derivative (formaldehyde adduct) of the drug substance, irbesartan, based upon analysis with LC/MS, LC/MS/MS, and chromatographic comparison to the synthetic hydroxymethyl degradation product. Laboratory studies demonstrated that the interaction of individual excipients with the drug substance at elevated temperature and polyethylene glycol (PEG) used in the coating material, Opadry II White, leads to the generation of this formaldehyde adduct. Spiking of formaldehyde to the solution of drug substance gradually produced this impurity and the kinetics studies demonstrated that the reaction between formaldehyde and irbesartan is a second order reaction with a rate constant of 2.6 x 10(-4) M(-1)min(-1) at 25 degrees C in an aqueous media. The redevelopment of the formulation by eliminating PEG from the Opadry II White dry-blend system was enabled by understanding the formaldehyde adduct formation.

摘要

在安博维薄膜包衣片低剂量制剂的长期稳定性研究(LTSS)过程中形成了一种降解产物。基于液相色谱/质谱(LC/MS)、液相色谱/串联质谱(LC/MS/MS)分析以及与合成羟甲基降解产物的色谱比较,该降解物被鉴定为药物厄贝沙坦的羟甲基衍生物(甲醛加合物)。实验室研究表明,在高温下各辅料与药物之间的相互作用以及包衣材料欧巴代II白色型(Opadry II White)中使用的聚乙二醇(PEG)会导致这种甲醛加合物的生成。向药物溶液中加入甲醛会逐渐产生这种杂质,动力学研究表明,在25℃的水性介质中,甲醛与厄贝沙坦之间的反应是二级反应,速率常数为2.6×10⁻⁴ M⁻¹ min⁻¹。通过了解甲醛加合物的形成过程,得以从欧巴代II白色型干混体系中去除PEG来重新开发该制剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验